Global Ophthalmic Viscosurgical Devices Market Size By Type (Dispersive, Cohesive), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2032

The Global Ophthalmic Viscosurgical Devices (OVD) Market was valued at USD 1.1 billion in 2023 and is projected to reach USD 1.85 billion by 2031, expanding at a CAGR of 6.5% from 2023 to 2031. The market is driven by the rising prevalence of cataracts and other age-related ophthalmic conditions, increasing geriatric population, and growing adoption of minimally invasive ophthalmic procedures. Ophthalmic viscosurgical devices play a critical role in maintaining anterior chamber stability, protecting intraocular tissues, and enabling safer and more efficient eye surgeries, especially cataract and glaucoma procedures.

Drivers:

1. Rising Prevalence of Age-related Eye Disorders:

Cataracts, glaucoma, and other age-related eye conditions are becoming more common due to the global aging population. This is a key driver increasing the demand for ophthalmic surgeries where OVDs are essential.

2. Technological Advancements in Ophthalmic Surgery:

Minimally invasive techniques and advanced surgical tools are boosting the use of high-performance OVDs, improving surgical precision and patient outcomes.

3. Increasing Number of Eye Surgeries:

The global increase in ophthalmic surgical procedures, particularly cataract extractions, is directly contributing to the growth of the OVD market.

Restraints:

1. High Cost of Surgical Procedures:

Despite growing demand, high treatment and device costs remain a barrier in low-income and underdeveloped regions, limiting widespread adoption.

2. Limited Access to Skilled Ophthalmologists:

In several developing regions, there is a shortage of trained professionals to conduct specialized surgeries requiring OVDs, affecting market penetration.

Opportunity:

1. Expanding Healthcare Infrastructure in Emerging Markets:

Countries across Asia-Pacific and Latin America are investing heavily in healthcare infrastructure, presenting growth opportunities for OVD adoption.

2. Development of Next-Gen Viscosurgical Products:

Ongoing research in developing dual-purpose and viscoadaptive OVDs is opening new market avenues focused on safety, efficacy, and surgical efficiency.

Market by System Type Insights:

Based on product type, the cohesive OVD segment dominated the market in 2023. Cohesive devices are preferred in standard cataract surgeries due to their ability to maintain space in the anterior chamber and ease of removal. However, viscoadaptive OVDs are anticipated to witness the fastest growth owing to their combined cohesive and dispersive properties, ideal for complex procedures such as posterior capsular rupture and glaucoma surgeries.

Market by End-use Insights:

Hospitals represented the largest end-use segment in 2023, accounting for over 60% of the global revenue share. The dominance is attributed to the increasing volume of ophthalmic surgeries performed in hospital settings equipped with comprehensive surgical infrastructure. Ambulatory surgical centers (ASCs) are expected to grow rapidly due to shorter turnaround times and cost-effective procedures.

Market by Regional Insights:

North America led the global OVD market in 2023, supported by a high rate of cataract surgeries, well-established healthcare systems, and early adoption of advanced surgical technologies. Asia-Pacific is poised to be the fastest-growing regional market due to rising healthcare investments, growing elderly population, and expanding access to ophthalmic care in countries like India and China.

Competitive Scenario:

Key players in the global ophthalmic viscosurgical devices market include Johnson & Johnson Vision, Alcon Inc., Bausch + Lomb, Carl Zeiss Meditec AG, Rayner Group, BVI Medical, and AbbVie Inc. These companies are focusing on innovations in viscoadaptive materials, expanding their geographic footprint, and entering strategic collaborations to enhance their market presence.

Scope of Work – Global Ophthalmic Viscosurgical Devices Market

Key Market Developments:

2023: Johnson & Johnson Vision introduced a new line of dual-function OVDs with improved dispersion and reformation properties for complex surgeries.

2024: Alcon partnered with a leading eye hospital chain in Asia to supply OVDs under a long-term distribution agreement.

2025: Bausch + Lomb expanded its product line in Europe by launching viscoadaptive OVDs tailored for combined cataract and glaucoma surgeries.

FAQs:

1) What is the current market size of the Global Ophthalmic Viscosurgical Devices Market?

The market size stood at USD 1.1 billion in 2023.

2) What is the major growth driver of the Global Ophthalmic Viscosurgical Devices Market?

Rising global prevalence of cataract surgeries and age-related eye conditions is the key growth driver.

3) Which is the largest region during the forecast period in the Global Ophthalmic Viscosurgical Devices Market?

North America leads the market due to high surgical volumes and advanced healthcare infrastructure.

4) Which segment accounted for the largest market share in Global Ophthalmic Viscosurgical Devices Market?

The cohesive OVD segment held the largest market share in 2023.

5) Who are the key market players in the Global Ophthalmic Viscosurgical Devices Market?

Key players include Johnson & Johnson Vision, Alcon Inc., Bausch + Lomb, Carl Zeiss Meditec AG, and Rayner Group.